As KIR+CD8+ T cells have been described at homeostasis and increase with progressive inflammation as an alternative mechanism to preserve peripheral tolerance, it is unclear whether tumor antigen specificity is required to impair anti-tumor immunity or whether the presence of KIR+CD8+ T cells is instead representative of host immunity more broadly. The gene discussed is KIR3DL1; the disease is neoplasm.